A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950) Meeting Abstract
| Authors: | Gounder, M.; Schöffski, P.; Villalobos, V.; Cote, G.; Chugh, R.; Chen, T. W. W.; Jahan, T.; Loggers, E. T.; Italiano, A.; Gupta, A.; Agulnik, M.; Attia, S.; Jones, R. L.; van Tine, B. A.; Demetri, G. D. D.; Roche, M.; Sapir, I.; Daigle, S.; Clawson, A.; Stacchiotti, S. |
| Abstract Title: | A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950) |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy299.014 |
| Language: | English |
| ACCESSION: | WOS:000459277303384 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy299.014 |
| Notes: | Meeting Abstract: 1615PD -- Appears on pages viii581-viii582 of the abstract book -- Source: Wos |
